Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
Market Analysis and Insights: Global Gastrointestinal Therapeutics Market
The global Gastrointestinal Therapeutics market size is projected to reach US$ 35190 million by 2026, from US$ 33290 million in 2020, at a CAGR of 5.3%% during 2021-2026.
Global Gastrointestinal Therapeutics Scope and Market Size
Gastrointestinal Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Gastrointestinal Therapeutics Breakdown Data by Type
Oral
Parenteral
Gastrointestinal Therapeutics Breakdown Data by Application
IBD
Irritable Bowel Syndrome (IBS)
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
Market Analysis and Insights: Global Gastrointestinal Therapeutics Market
The global Gastrointestinal Therapeutics market size is projected to reach US$ 35190 million by 2026, from US$ 33290 million in 2020, at a CAGR of 5.3%% during 2021-2026.
Global Gastrointestinal Therapeutics Scope and Market Size
Gastrointestinal Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen
Gastrointestinal Therapeutics Breakdown Data by Type
Oral
Parenteral
Gastrointestinal Therapeutics Breakdown Data by Application
IBD
Irritable Bowel Syndrome (IBS)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 IBD
1.5.3 Irritable Bowel Syndrome (IBS)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics Market Perspective (2015-2026)
2.2 Global Gastrointestinal Therapeutics Growth Trends by Regions
2.2.1 Gastrointestinal Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastrointestinal Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gastrointestinal Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics Players by Market Size
3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Therapeutics Market Concentration Ratio
3.2.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2019
3.3 Gastrointestinal Therapeutics Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Therapeutics Product Solution and Service
3.5 Date of Enter into Gastrointestinal Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Therapeutics Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size (2015-2020)
6.2 Gastrointestinal Therapeutics Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size (2015-2020)
7.2 Gastrointestinal Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Gastrointestinal Therapeutics Market Size (2015-2020)
8.2 Gastrointestinal Therapeutics Key Players in China (2019-2020)
8.3 China Gastrointestinal Therapeutics Market Size by Type (2015-2020)
8.4 China Gastrointestinal Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gastrointestinal Therapeutics Market Size (2015-2020)
9.2 Gastrointestinal Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2015-2020)
10.2 Gastrointestinal Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Gastrointestinal Therapeutics Market Size (2015-2020)
11.2 Gastrointestinal Therapeutics Key Players in India (2019-2020)
11.3 India Gastrointestinal Therapeutics Market Size by Type (2015-2020)
11.4 India Gastrointestinal Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gastrointestinal Therapeutics Market Size (2015-2020)
12.2 Gastrointestinal Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Gastrointestinal Therapeutics Introduction
13.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Gastrointestinal Therapeutics Introduction
13.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
13.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Takeda
13.4.1 Takeda Company Details
13.4.2 Takeda Business Overview
13.4.3 Takeda Gastrointestinal Therapeutics Introduction
13.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.4.5 Takeda Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Gastrointestinal Therapeutics Introduction
13.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Gastrointestinal Therapeutics Introduction
13.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Gastrointestinal Therapeutics Introduction
13.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.7.5 Merck Recent Development
13.8 F. Hoffmann-La Roche
13.8.1 F. Hoffmann-La Roche Company Details
13.8.2 F. Hoffmann-La Roche Business Overview
13.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
13.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.8.5 F. Hoffmann-La Roche Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview
13.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
13.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.9.5 Eli Lilly Recent Development
13.10 AstraZeneca
13.10.1 AstraZeneca Company Details
13.10.2 AstraZeneca Business Overview
13.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
13.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.10.5 AstraZeneca Recent Development
13.11 Procter & Gamble
10.11.1 Procter & Gamble Company Details
10.11.2 Procter & Gamble Business Overview
10.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
10.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.11.5 Procter & Gamble Recent Development
13.12 Tillotts Pharma
10.12.1 Tillotts Pharma Company Details
10.12.2 Tillotts Pharma Business Overview
10.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
10.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.12.5 Tillotts Pharma Recent Development
13.13 Takeda
10.13.1 Takeda Company Details
10.13.2 Takeda Business Overview
10.13.3 Takeda Gastrointestinal Therapeutics Introduction
10.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.13.5 Takeda Recent Development
13.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Details
10.14.2 GlaxoSmithKline Business Overview
10.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
10.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.14.5 GlaxoSmithKline Recent Development
13.15 Amgen
10.15.1 Amgen Company Details
10.15.2 Amgen Business Overview
10.15.3 Amgen Gastrointestinal Therapeutics Introduction
10.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.15.5 Amgen Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 IBD
1.5.3 Irritable Bowel Syndrome (IBS)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Therapeutics Market Perspective (2015-2026)
2.2 Global Gastrointestinal Therapeutics Growth Trends by Regions
2.2.1 Gastrointestinal Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastrointestinal Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gastrointestinal Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Therapeutics Players by Market Size
3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Therapeutics Market Concentration Ratio
3.2.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2019
3.3 Gastrointestinal Therapeutics Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Therapeutics Product Solution and Service
3.5 Date of Enter into Gastrointestinal Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Therapeutics Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gastrointestinal Therapeutics Market Size (2015-2020)
6.2 Gastrointestinal Therapeutics Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gastrointestinal Therapeutics Market Size (2015-2020)
7.2 Gastrointestinal Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Gastrointestinal Therapeutics Market Size (2015-2020)
8.2 Gastrointestinal Therapeutics Key Players in China (2019-2020)
8.3 China Gastrointestinal Therapeutics Market Size by Type (2015-2020)
8.4 China Gastrointestinal Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gastrointestinal Therapeutics Market Size (2015-2020)
9.2 Gastrointestinal Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2015-2020)
10.2 Gastrointestinal Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Gastrointestinal Therapeutics Market Size (2015-2020)
11.2 Gastrointestinal Therapeutics Key Players in India (2019-2020)
11.3 India Gastrointestinal Therapeutics Market Size by Type (2015-2020)
11.4 India Gastrointestinal Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gastrointestinal Therapeutics Market Size (2015-2020)
12.2 Gastrointestinal Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Gastrointestinal Therapeutics Introduction
13.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Allergan
13.2.1 Allergan Company Details
13.2.2 Allergan Business Overview
13.2.3 Allergan Gastrointestinal Therapeutics Introduction
13.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.2.5 Allergan Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
13.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Takeda
13.4.1 Takeda Company Details
13.4.2 Takeda Business Overview
13.4.3 Takeda Gastrointestinal Therapeutics Introduction
13.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.4.5 Takeda Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Gastrointestinal Therapeutics Introduction
13.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Gastrointestinal Therapeutics Introduction
13.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Gastrointestinal Therapeutics Introduction
13.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.7.5 Merck Recent Development
13.8 F. Hoffmann-La Roche
13.8.1 F. Hoffmann-La Roche Company Details
13.8.2 F. Hoffmann-La Roche Business Overview
13.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
13.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.8.5 F. Hoffmann-La Roche Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview
13.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
13.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.9.5 Eli Lilly Recent Development
13.10 AstraZeneca
13.10.1 AstraZeneca Company Details
13.10.2 AstraZeneca Business Overview
13.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
13.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020)
13.10.5 AstraZeneca Recent Development
13.11 Procter & Gamble
10.11.1 Procter & Gamble Company Details
10.11.2 Procter & Gamble Business Overview
10.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
10.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.11.5 Procter & Gamble Recent Development
13.12 Tillotts Pharma
10.12.1 Tillotts Pharma Company Details
10.12.2 Tillotts Pharma Business Overview
10.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
10.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.12.5 Tillotts Pharma Recent Development
13.13 Takeda
10.13.1 Takeda Company Details
10.13.2 Takeda Business Overview
10.13.3 Takeda Gastrointestinal Therapeutics Introduction
10.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.13.5 Takeda Recent Development
13.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Details
10.14.2 GlaxoSmithKline Business Overview
10.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
10.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.14.5 GlaxoSmithKline Recent Development
13.15 Amgen
10.15.1 Amgen Company Details
10.15.2 Amgen Business Overview
10.15.3 Amgen Gastrointestinal Therapeutics Introduction
10.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020)
10.15.5 Amgen Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
